Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2021-02-12 2021-02-12
Drug Identification Number 02358263 02358263
Brand name TEVA-LOSARTAN/HCTZ TEVA-LOSARTAN/HCTZ
Common or Proper name LOSARTAN/HCTZ 50/12.5MG TABS LOSARTAN/HCTZ 50/12.5MG TABS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM HYDROCHLOROTHIAZIDE
Strength(s) 50.0MG 12.5MG 50.0MG 12.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size PP 30 PP 30
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-02-05 2021-02-05
Remaining supply date 2021-02-05 2021-02-05
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Item is disc Item is disc
Health Canada comments